Intramammary Tumor Location and Ipsilateral Lymphatic Spread in Early Breast Cancer Patients Using One‐Step Nucleic Acid Amplification (OSNA) Assay
Open Access
- 1 January 2024
- journal article
- research article
- Published by Wiley in The Breast Journal
- Vol. 2024 (1) , 4864443
Abstract
Establishing an accurate prognosis for women diagnosed with breast cancer (BC) is extremely challenging. Axillary lymph node (ALN) evaluation is considered of major prognostic value. The one‐step nucleic acid amplification (OSNA) assay is currently used for assessing axillary sentinel lymph node (SLN) status in BC. Additionally, total tumor load (TTL) may help predict further metastatic axillary involvement beyond the SLN. The prognostic value of primary BC location remains controversial due to lack of consensus on the biological differences among tumors at various sites. Evidence suggests that tumors in the internal quadrants (INLs) have worse prognosis compared to those in the external quadrants. Furthermore, ALN involvement is believed to be mainly associated with external quadrant tumors, mainly due to the lymphatic drainage system of the breast. This pilot observational study, despite lacking a control group and having a relatively small sample size, is the first to evaluate the potential relationship between primary BC location and ALN metastasis using the OSNA assay. A sample of consecutive BC patients undergoing axillary staging with the OSNA assay were included. Tumors were categorized into three groups based on primary location: external quadrants and axillary tail (EXL), INLs, and nipple and areola location (NAL). Although not statistically significant, the INL group exhibited a higher mean TTL. Additionally, no significant differences were observed between groups concerning SLN detection techniques, SLN status, number of metastatic SLN, or mean TTL. These findings support the use of the innovative tracer superparamagnetic iron oxide regardless of tumor site. This study underscores the importance of understanding the relationship between BC location and ALN status, which may improve prognostic stratification and targeted therapies based on tumor site. If these observations are confirmed in larger, multicentric studies, the potential conclusions may shift the paradigm of INL tumor treatment, significantly impacting clinical practice and research.Keywords
This publication has 40 references indexed in Scilit:
- Internal mammary lymph node metastasis in breast cancer patients based on anatomical imaging and functional imagingBreast Cancer, 2022
- The lymphatic system and sentinel lymph nodes: conduit for cancer metastasisClinical & Experimental Metastasis, 2021
- Tumor Site and Breast Cancer PrognosisClinical Breast Cancer, 2018
- Molecular Subtypes and Lower Inner Quadrant Tumors in Breast Cancer: Debate Is Still OngoingClinical Breast Cancer, 2017
- Sentinel and nonsentinel lymph node assessment using a combination of one-step nucleic acid amplification and conventional histological examinationThe Breast, 2013
- Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patientsBreast Cancer Research and Treatment, 2013
- Primary tumor location impacts breast cancer survivalThe American Journal of Surgery, 2008
- Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Lymph node metastasis in breast cancer: common prognostic markers lack predictive value.Annals of Surgical Oncology, 1998
- Identification of women with T1-T2 breast cancer at low risk of positive axillary nodesJournal of Surgical Oncology, 1997